Rosendaal FR - Search Results

1

Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis.

Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Stegeman BH, et al. Among authors: rosendaal fr. BMJ. 2013 Sep 12;347:f5298. doi: 10.1136/bmj.f5298. BMJ. 2013. PMID: 24030561 Free PMC article. Review.

2

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP. Bloemenkamp KW, et al. Among authors: rosendaal fr. Lancet. 1995 Dec 16;346(8990):1593-6. doi: 10.1016/s0140-6736(95)91929-5. Lancet. 1995. PMID: 7500751

3

Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties.

Koster T, Small RA, Rosendaal FR, Helmerhorst FM. Koster T, et al. Among authors: rosendaal fr. J Intern Med. 1995 Jul;238(1):31-7. doi: 10.1111/j.1365-2796.1995.tb00896.x. J Intern Med. 1995. PMID: 7608644

4

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Vandenbroucke JP, et al. Among authors: rosendaal fr. Lancet. 1994 Nov 26;344(8935):1453-7. doi: 10.1016/s0140-6736(94)90286-0. Lancet. 1994. PMID: 7968118 Free article.

5

Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands.

Vandenbroucke JP, Bloemenkamp KW, Helmerhorst FM, Rosendaal FR. Vandenbroucke JP, et al. Among authors: rosendaal fr. Lancet. 1996 Aug 10;348(9024):401-2. doi: 10.1016/s0140-6736(96)24032-2. Lancet. 1996. PMID: 8709744 No abstract available.

6

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Vandenbroucke JP, van der Meer FJ, Helmerhorst FM, Rosendaal FR. Vandenbroucke JP, et al. Among authors: rosendaal fr. BMJ. 1996 Nov 2;313(7065):1127-30. doi: 10.1136/bmj.313.7065.1127. BMJ. 1996. PMID: 8916702 Free PMC article. Review.

7

Third-generation oral contraceptives and venous thrombosis.

Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KW, Rosendaal FR. Vandenbroucke JP, et al. Among authors: rosendaal fr. Lancet. 1997 Mar 8;349(9053):731; author reply 732-3. doi: 10.1016/S0140-6736(05)60172-9. Lancet. 1997. PMID: 9078225 Free article. No abstract available.

8

Risk of oral contraceptives and recency of market introduction.

Vandenbroucke JP, Bloemenkamp KW, Helmerhorst FM, Rosendaal FR. Vandenbroucke JP, et al. Among authors: rosendaal fr. Contraception. 1997 Mar;55(3):191-2; discussion 192-4. doi: 10.1016/s0010-7824(97)00001-2. Contraception. 1997. PMID: 9115010 Free article. No abstract available.

9

Oral contraceptives and thrombotic disease: risk of venous thromboembolism.

Helmerhorst FM, Bloemenkamp KW, Rosendaal FR, Vandenbroucke JP. Helmerhorst FM, et al. Among authors: rosendaal fr. Thromb Haemost. 1997 Jul;78(1):327-33. Thromb Haemost. 1997. PMID: 9198174 Free article. Review.

10

Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation.

Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KW, Rosendaal FR. Vandenbroucke JP, et al. Among authors: rosendaal fr. Am J Obstet Gynecol. 1997 Oct;177(4):887-91. doi: 10.1016/s0002-9378(97)70289-8. Am J Obstet Gynecol. 1997. PMID: 9369840 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,205 results

Search Page

Filters